182 related articles for article (PubMed ID: 7626487)
1. Growth of the androgen-dependent tumor of the prostate: role of androgens and of locally expressed growth modulatory factors.
Limonta P; Dondi D; Marelli MM; Moretti RM; Negri-Cesi P; Motta M
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):401-5. PubMed ID: 7626487
[TBL] [Abstract][Full Text] [Related]
2. Androgen-dependent prostatic tumors: biosynthesis and possible actions of LHRH.
Limonta P; Moretti RM; Dondi D; Marelli MM; Motta M
J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):347-50. PubMed ID: 8043499
[TBL] [Abstract][Full Text] [Related]
3. Role of growth factors, steroid and peptide hormones in the regulation of human prostatic tumor growth.
Motta M; Dondi D; Moretti RM; Montagnani Marelli M; Pimpinelli F; Maggi R; Limonta P
J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):107-11. PubMed ID: 8603030
[TBL] [Abstract][Full Text] [Related]
4. Growth factors in steroid-responsive prostatic tumor cells.
Dondi D; Moretti RM; Marelli MM; Motta M; Limonta P
Steroids; 1996 Apr; 61(4):222-5. PubMed ID: 8733005
[TBL] [Abstract][Full Text] [Related]
5. Expression of luteinizing hormone-releasing hormone mRNA in the human prostatic cancer cell line LNCaP.
Limonta P; Dondi D; Moretti RM; Fermo D; Garattini E; Motta M
J Clin Endocrinol Metab; 1993 Mar; 76(3):797-800. PubMed ID: 8445038
[TBL] [Abstract][Full Text] [Related]
6. [Androgen regulation of secreted growth factors in prostate carcinoma cell and tumor lines].
Kellner U; Wagner B; Otto U; Voigt KD; Dietel M; Knabbe C
Verh Dtsch Ges Pathol; 1993; 77():124-8. PubMed ID: 7511269
[TBL] [Abstract][Full Text] [Related]
7. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells.
Seth D; Shaw K; Jazayeri J; Leedman PJ
Br J Cancer; 1999 May; 80(5-6):657-69. PubMed ID: 10360641
[TBL] [Abstract][Full Text] [Related]
8. Luteinizing hormone-releasing hormone agonists interfere with the stimulatory actions of epidermal growth factor in human prostatic cancer cell lines, LNCaP and DU 145.
Moretti RM; Marelli MM; Dondi D; Poletti A; Martini L; Motta M; Limonta P
J Clin Endocrinol Metab; 1996 Nov; 81(11):3930-7. PubMed ID: 8923840
[TBL] [Abstract][Full Text] [Related]
9. Androgen metabolism in the human prostatic cancer cell line LNCaP.
Negri-Cesi P; Motta M
J Steroid Biochem Mol Biol; 1994 Oct; 51(1-2):89-96. PubMed ID: 7947355
[TBL] [Abstract][Full Text] [Related]
10. Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-alpha (TGF-alpha) and epidermal growth factor (EGF)/TGF-alpha receptor.
Liu XH; Wiley HS; Meikle AW
J Clin Endocrinol Metab; 1993 Dec; 77(6):1472-8. PubMed ID: 8263129
[TBL] [Abstract][Full Text] [Related]
11. Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones.
Schuurmans AL; Bolt J; Veldscholte J; Mulder E
J Steroid Biochem Mol Biol; 1991; 40(1-3):193-7. PubMed ID: 1958520
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor-dependent stimulation of amphiregulin expression in androgen-stimulated human prostate cancer cells.
Sehgal I; Bailey J; Hitzemann K; Pittelkow MR; Maihle NJ
Mol Biol Cell; 1994 Mar; 5(3):339-47. PubMed ID: 8049525
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop.
Dondi D; Limonta P; Moretti RM; Marelli MM; Garattini E; Motta M
Cancer Res; 1994 Aug; 54(15):4091-5. PubMed ID: 8033142
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP.
Limonta P; Dondi D; Moretti RM; Maggi R; Motta M
J Clin Endocrinol Metab; 1992 Jul; 75(1):207-12. PubMed ID: 1320049
[TBL] [Abstract][Full Text] [Related]
15. Effects of LHRH agonists on the growth of human prostatic tumor cells: "in vitro" and "in vivo" studies.
Montagnani Marelli M; Moretti RM; Dondi D; Limonta P; Motta M
Arch Ital Urol Androl; 1997 Sep; 69(4):257-63. PubMed ID: 9396187
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.
Tørring N; Jørgensen PE; Sørensen BS; Nexø E
Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta1 is a mediator of androgen-regulated growth arrest in an androgen-responsive prostatic cancer cell line, LNCaP.
Kim IY; Kim JH; Zelner DJ; Ahn HJ; Sensibar JA; Lee C
Endocrinology; 1996 Mar; 137(3):991-9. PubMed ID: 8603613
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of anchorage independent growth of human prostate cancer cell line LNCap].
Hara Y
Nihon Hinyokika Gakkai Zasshi; 1992 Sep; 83(9):1429-35. PubMed ID: 1434284
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells.
Sherwood ER; Van Dongen JL; Wood CG; Liao S; Kozlowski JM; Lee C
Br J Cancer; 1998 Mar; 77(6):855-61. PubMed ID: 9528825
[TBL] [Abstract][Full Text] [Related]
20. Androgens and transforming growth factor beta modulate the growth response to epidermal growth factor in human prostatic tumor cells (LNCaP).
Schuurmans AL; Bolt J; Mulder E
Mol Cell Endocrinol; 1988 Nov; 60(1):101-4. PubMed ID: 3265111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
